Syndax Pharmaceuticals Inc — All Filings
629 total filings on record
Public companies registered with the SEC are required to file periodic reports, disclosures, and notices throughout the year. The most important are the 10-K (annual report), 10-Q (quarterly report), and 8-K (material event notice). Use the filters below to narrow by form type.
All
10-K
10-K/A
10-Q
144
3
4
4/A
424B4
424B5
8-A12B
8-K
8-K/A
ARS
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
DRS
DRS/A
DRSLTR
EFFECT
PRE 14A
REGDEX
RW
S-1
S-1/A
S-3
S-3ASR
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SCHEDULE 13G/A | — | 0000102909-26-002306 | Mar 27, 2026 | — |
| S-8 | S-8 | 0001193125-26-076822 | Feb 26, 2026 | — |
| 8-K | 8-K | 0001193125-26-076522 | Feb 26, 2026 | — |
| 10-K | 10-K | 0001193125-26-076536 | Feb 26, 2026 | Dec 31, 2025 |
| 4 | 4 | 0001193125-26-043813 | Feb 10, 2026 | Feb 9, 2026 |
| 4 | 4 | 0001193125-26-043814 | Feb 10, 2026 | Feb 9, 2026 |
| 144 | — | 0001959173-26-000771 | Feb 9, 2026 | — |
| 144 | — | 0001959173-26-000773 | Feb 9, 2026 | — |
| 4 | 4 | 0001193125-26-041200 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041344 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041334 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041500 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041412 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041194 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041497 | Feb 6, 2026 | Feb 4, 2026 |
| 144 | — | 0001959173-26-000723 | Feb 6, 2026 | — |
| 144 | — | 0001959173-26-000725 | Feb 6, 2026 | — |
| 4 | 4 | 0001193125-26-041192 | Feb 6, 2026 | Feb 4, 2026 |
| 4 | 4 | 0001193125-26-041167 | Feb 6, 2026 | Feb 4, 2026 |
| SCHEDULE 13G/A | — | 0000102909-26-000252 | Jan 30, 2026 | — |
| 8-K | 8-K | 0001193125-26-010486 | Jan 12, 2026 | — |
| 8-K | 8-K | 0001193125-25-326961 | Dec 19, 2025 | Dec 18, 2025 |
| 4 | 4 | 0001193125-25-303941 | Dec 1, 2025 | — |
| 8-K | 8-K | 0001193125-25-262509 | Nov 3, 2025 | — |
| 10-Q | 10-Q | 0001193125-25-262521 | Nov 3, 2025 | Sep 30, 2025 |
| 8-K | 8-K | 0001193125-25-250052 | Oct 24, 2025 | — |
| 4 | 4 | 0000950170-25-113659 | Sep 8, 2025 | — |
| 144 | — | 0001950047-25-006849 | Sep 8, 2025 | — |
| 144 | — | 0001950047-25-005995 | Aug 18, 2025 | — |
| SCHEDULE 13G | — | 0000902664-25-003741 | Aug 18, 2025 | — |
| 4 | 4 | 0000950170-25-109815 | Aug 18, 2025 | Aug 14, 2025 |
| SCHEDULE 13G/A | — | 0000902664-25-003706 | Aug 14, 2025 | — |
| 144 | — | 0001950047-25-005839 | Aug 14, 2025 | — |
| 4 | 4 | 0000950170-25-105258 | Aug 7, 2025 | Jul 31, 2025 |
| 8-K | 8-K | 0000950170-25-101974 | Aug 4, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-101985 | Aug 4, 2025 | Jun 30, 2025 |
| 4 | 4 | 0000950170-25-096948 | Jul 18, 2025 | Jul 16, 2025 |
| 4 | 4 | 0000950170-25-096947 | Jul 18, 2025 | Jul 16, 2025 |
| 144 | — | 0001959173-25-004605 | Jul 16, 2025 | — |
| 144 | — | 0001959173-25-004606 | Jul 16, 2025 | — |
| 144 | — | 0001959173-25-004535 | Jul 10, 2025 | — |
| 8-K | 8-K | 0000950170-25-090205 | Jun 26, 2025 | Jun 24, 2025 |
| 4 | 4 | 0000950170-25-074289 | May 19, 2025 | — |
| 4 | 4 | 0000950170-25-074297 | May 19, 2025 | — |
| 4 | 4 | 0000950170-25-074301 | May 19, 2025 | May 16, 2025 |
| 4 | 4 | 0000950170-25-074304 | May 19, 2025 | — |
| 8-K | 8-K | 0000950170-25-073555 | May 16, 2025 | May 12, 2025 |
| 3 | 3 | 0000950170-25-073559 | May 16, 2025 | May 12, 2025 |
| 8-K | 8-K | 0000950170-25-063514 | May 5, 2025 | — |
| 10-Q | 10-Q | 0000950170-25-063518 | May 5, 2025 | Mar 31, 2025 |